COA survey of independent community oncology practices shows insurer requirements delay treatment, override clinical ...

Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives.

An oncology research student was diagnosed with breast cancer in her 20s. She said powerlifting helped her recover and stay strong through treatment.

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

Adults living in rural communities often travel long distances when seeking treatment for cancer, but distant travel may not ...

Actinium-225, an alpha-emitting radiopharmaceutical, targets cancer cells precisely, sparing healthy tissue, and is being trialed for advanced breast cancer in the U.S. The phase 1b/2 trial involves ...

Patients with breast cancer living in states with expanded Medicaid eligibility, have seen survival gains, raising more concerns about the impact of recent changes to the program.

The collaboration enables easier patient access to medical records and personalized navigation to advance patient ...

Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...